Development of two Salmonella-based oral vaccines against human respiratory syncytial virus
Human respiratory syncytial virus is the most common cause of bronchiolitis and other respiratory infections in infants and the elderly worldwide. We have developed two new oral vaccines using Salmonella typhi TY21a to carry and express the immunogenic epitopes of RSV fusion (F) and attachment (G) g...
Main Authors: | Jalilian, F. Azizi, Yusoff, K., Suhaimi, S., Amini, R., Sekawi, Z., Jahanshiri, F. |
---|---|
Format: | Article |
Published: |
BIOLIFE, s.a.s.
2015
|
Similar Items
-
Development of Salmonella-based DNA vaccine against respiratory syncytial virus.
by: Suhaimi, Siti Syazani
Published: (2011) -
Development of a Novel Oral Vaccine Against Human Resipratory Syncytial Virus
by: Jalilian, Farid Azizi
Published: (2011) -
Dynamics of the bacterially expressed conserved immunogenic region of the human respiratory syncytial virus G protein.
by: Jalilian, Farid Azizi, et al.
Published: (2011) -
A Putative Oral Vaccine based on Live Lactococci Expressing the Surface Glycoproteins Respiratory Syncytial Virus.
by: Lim, Erin Swee Hua
Published: (2010) -
Multiepitope-based subunit vaccine design and evaluation against respiratory syncytial virus using reverse vaccinology approach
by: ul Qamar, Muhammad Tahir, et al.
Published: (2020)